Onkologie. 2010:4(4):256-259
Medulloblastoma, an embryonal neuroectodermal tumor of the cerebellum, is the most common form of malignant brain tumor of childhood.
10–12 new cases occur in the Czech Republic each year. Current treatment, which combines modern techniques of neurosurgical
resection and radiotherapy, and adjuvant chemotherapy, has improved survival substantially. The intensity of multimodal therapy is based
on clinical criteria of age, metastatic disease and the extent of surgical resection. Nevertheless, 19–30 % of average risk and 30–70 % of
high risk patients experience relapses within 5 years from initial presentation. Identification of biological prognostic markers and cellular
targets will result in risk-adapted treatment, which is crucial for improving cure rates and reducing long-term sequelae.
Published: October 1, 2010 Show citation